Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104926734A reveals a high-yield flibanserin synthesis route. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN103524408A details a high-yield, water-based synthesis of 7-Chloroquinaldine using SDS and phosphomolybdic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1229366C reveals a superior 3-step route for Dronedarone intermediates, offering reduced waste and higher yields for reliable pharmaceutical supply chains.
Patent CN103524408A details a high-yield aqueous synthesis of 7-chloroquinaldine using SDS and phosphomolybdic acid, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN113788765B reveals a ligand-free carbonylation method reducing costs and enhancing supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN103524408A details a high-yield aqueous synthesis of 7-Chloroquinaldine using SDS and phosphomolybdic acid, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102126960A details a high-selectivity synthesis of p-nitrobenzaldehyde using aerobic oxidation. Achieve >99% purity and reduced waste for reliable supply.
Advanced synthesis of 5-biphenyl-4-ylmethylpyrrolidin-2-one via patent CN101631765B. Enhances purity and supply chain stability for pharmaceutical intermediates manufacturing.
Advanced synthesis of high-purity butylphthalide via safe aqueous reduction and vacuum distillation. Ideal for reliable pharma intermediate supply chains.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Patent CN1261351A details a novel iodine-catalyzed route for pyrazoles, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN109320461B details a novel route for 2-n-propyl-4-methyl-6-carboxybenzimidazole, offering superior purity and cost reduction in API manufacturing.
Patent CN110257351A reveals high-activity enzyme mutants for chiral alcohol synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN105131015B reveals a green solid acid method for 7-AVCA. This offers cost reduction and supply chain reliability for antibiotic manufacturers.
Novel synthesis of 1,3-disubstituted pyrazoles as AR antagonists. Efficient route for pharma intermediates with scalable steps and high purity.
Patent CN115677559A reveals a one-step microwave synthesis for tetrahydrocarbazolone, offering significant cost reduction and high purity for pharmaceutical supply chains.
Patent CN106866466B details SO3 sulfonation for high-purity intermediates. This method reduces waste acid and ensures supply chain stability for global buyers.
Patent CN110295040B reveals a novel Suzuki coupling route for high-purity AIE compounds, offering significant cost reduction in electronic chemical manufacturing and reliable supply.
Patent CN115677559A reveals a microwave-assisted one-step synthesis for high-purity ondansetron intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.